Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase 3, Multicenter, Open-label, 12 Month Extension Safety and Tolerability Study of SPD489 in the Treatment of Adults With Binge Eating Disorder

NCT01657019 is registered in ClinicalTrials.gov with Shire as lead sponsor.

NCT NCT01657019
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01657019 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase 3, Multicenter, Open-label, 12 Month Extension Safety and Tolerability Study of SPD489 in the Treatment of Adults With Binge Eating Disorder
Lead sponsor
Shire
Phase
Phase 3
Overall status
Completed
Start date
August 21, 2012
Completion date
October 21, 2014
Enrollment
604 (actual)
Sites
89

Conditions

As the registry lists them; a condition with its own page is linked.

binge eating disorder